Correlation Between Design Therapeutics and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Lyell Immunopharma, you can compare the effects of market volatilities on Design Therapeutics and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Lyell Immunopharma.
Diversification Opportunities for Design Therapeutics and Lyell Immunopharma
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Design and Lyell is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between Design Therapeutics and Lyell Immunopharma
Given the investment horizon of 90 days Design Therapeutics is expected to under-perform the Lyell Immunopharma. In addition to that, Design Therapeutics is 1.51 times more volatile than Lyell Immunopharma. It trades about -0.1 of its total potential returns per unit of risk. Lyell Immunopharma is currently generating about -0.1 per unit of volatility. If you would invest 64.00 in Lyell Immunopharma on October 20, 2024 and sell it today you would lose (6.40) from holding Lyell Immunopharma or give up 10.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Design Therapeutics vs. Lyell Immunopharma
Performance |
Timeline |
Design Therapeutics |
Lyell Immunopharma |
Design Therapeutics and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and Lyell Immunopharma
The main advantage of trading using opposite Design Therapeutics and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.Design Therapeutics vs. Agilent Technologies | Design Therapeutics vs. Equillium | Design Therapeutics vs. 23Andme Holding Co | Design Therapeutics vs. DiaMedica Therapeutics |
Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |